GNC announced that it has reached an agreement with the New York attorney general (NYAG) that affirms the company’s Herbal Plus products were in full compliance with the federal Food and Drug Administration (FDA) current good manufacturing practice (cGMP) requirements and acknowledges GNC’s full cooperation with the attorney general’s inquiries.
In its response to the NYAG’s inquiry, GNC provided the results of rigorous tests conducted both internally and by independent third parties. These tests provided conclusive evidence that GNC’s products are safe, pure, properly labeled and in full compliance with all regulatory requirements. The testing also demonstrated that the company’s products contain all herbal extracts listed on their respective labels.
In addition, a former senior FDA cGMP expert performed a comprehensive review of GNC’s manufacturing processes for the products at issue and found them to be in compliance with all applicable requirements.
Accordingly, GNC has restored its full assortment of Herbal Plus products to all GNC stores in New York State. GNC also announced that it will expand its testing processes deeper into its supply chain by leading ongoing industry efforts to integrate source material traceability standards and enhance certain other aspects of its operations to provide consumers even greater confidence in its products.
GNC says that it believes these measures, which would not have impacted availability of the products subject to this review, will result in the adoption of stricter minimum standards across the broader industry.
In a related New York Times article earlier this week, Mark Blumenthal, executive director of the American Botanical Council, said he applauded GNC for reaching an agreement with New York and putting new procedures into effect, but he also worried that actions at the state level could create “a patchwork quilt of different quality standards and requirements” across the country.